Table 2.

Neurological follow-up across the three clinical scenarios of ATTRv.

Patient category	Clinical evaluation	Neurophysiological studies
Asymptomatic Carrier	Baseline and every 2 years during the 15 years before PADO	Baseline and every 2 years during the 15 years before PADO
Cardiological phenotype	Every 6 months	Every 6 months
Neurological/mixed phenotype	Every 6 months	Annually

PADO, predicted age of disease onset.